Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Relaxation and crystallization of amorphous carbamazepine studied by terahertz pulsed spectroscopy.

Zeitler JA, Taday PF, Pepper M, Rades T.

J Pharm Sci. 2007 Oct;96(10):2703-9.

PMID:
17696163
2.

Drug hydrate systems and dehydration processes studied by terahertz pulsed spectroscopy.

Zeitler JA, Kogermann K, Rantanen J, Rades T, Taday PF, Pepper M, Aaltonen J, Strachan CJ.

Int J Pharm. 2007 Apr 4;334(1-2):78-84. Epub 2006 Oct 21.

PMID:
17129691
3.
4.

Dielectric study of the molecular mobility and the isothermal crystallization kinetics of an amorphous pharmaceutical drug substance.

Alie J, Menegotto J, Cardon P, Duplaa H, Caron A, Lacabanne C, Bauer M.

J Pharm Sci. 2004 Jan;93(1):218-33.

PMID:
14648651
5.

Prediction of the onset of crystallization of amorphous sucrose below the calorimetric glass transition temperature from correlations with mobility.

Bhugra C, Rambhatla S, Bakri A, Duddu SP, Miller DP, Pikal MJ, Lechuga-Ballesteros D.

J Pharm Sci. 2007 May;96(5):1258-69.

PMID:
17455303
6.

Effect of n-scCO(2) on crystalline to amorphous conversion of carbamazepine.

Ugaonkar S, Nunes AC, Needham TE.

Int J Pharm. 2007 Mar 21;333(1-2):152-61. Epub 2006 Dec 14.

PMID:
17223289
7.

Determination of hydrate transition temperature using transformation kinetics obtained by Raman spectroscopy.

Wikström H, Kakidas C, Taylor LS.

J Pharm Biomed Anal. 2009 Feb 20;49(2):247-52. doi: 10.1016/j.jpba.2008.11.008. Epub 2008 Nov 18.

PMID:
19112003
8.

In situ dehydration of carbamazepine dihydrate: a novel technique to prepare amorphous anhydrous carbamazepine.

Li Y, Han J, Zhang GG, Grant DJ, Suryanarayanan R.

Pharm Dev Technol. 2000;5(2):257-66.

PMID:
10810755
9.

Understanding the influence of polymorphism on phonon spectra: lattice dynamics calculations and terahertz spectroscopy of carbamazepine.

Day GM, Zeitler JA, Jones W, Rades T, Taday PF.

J Phys Chem B. 2006 Jan 12;110(1):447-56.

PMID:
16471555
10.

Quantitative phase analyses through the Rietveld method with X-ray powder diffraction data of heat-treated carbamazepine form III.

Antonio SG, Benini FR, Ferreira FF, Rosa PC, Paiva-santos Cde O.

J Pharm Sci. 2011 Jul;100(7):2658-64. doi: 10.1002/jps.22482. Epub 2011 Jan 21.

PMID:
21259240
11.

The influence of thermal and mechanical preparative techniques on the amorphous state of four poorly soluble compounds.

Patterson JE, James MB, Forster AH, Lancaster RW, Butler JM, Rades T.

J Pharm Sci. 2005 Sep;94(9):1998-2012.

PMID:
16052554
12.

Determination of carbamazepine polymorphic contents in double-layered tablets using transmittance- and reflectance-near-infrared spectroscopy involving chemometrics.

Otsuka M, Fukui Y.

Drug Dev Ind Pharm. 2010 Dec;36(12):1404-12. doi: 10.3109/03639045.2010.487262. Epub 2010 Jun 1.

PMID:
20515394
13.

Analysis of solid-state transformations of pharmaceutical compounds using vibrational spectroscopy.

Heinz A, Strachan CJ, Gordon KC, Rades T.

J Pharm Pharmacol. 2009 Aug;61(8):971-88. doi: 10.1211/jpp/61.08.0001. Review.

PMID:
19703341
14.

Solid-state transition mechanism in carbamazepine polymorphs by time-resolved terahertz spectroscopy.

Zeitler JA, Taday PF, Gordon KC, Pepper M, Rades T.

Chemphyschem. 2007 Sep 17;8(13):1924-7. No abstract available.

PMID:
17647253
15.

Terahertz pulsed spectroscopy and imaging in the pharmaceutical setting--a review.

Zeitler JA, Taday PF, Newnham DA, Pepper M, Gordon KC, Rades T.

J Pharm Pharmacol. 2007 Feb;59(2):209-23. Review.

PMID:
17270075
16.

Polymorph characterization of active pharmaceutical ingredients (APIs) using low-frequency Raman spectroscopy.

Larkin PJ, Dabros M, Sarsfield B, Chan E, Carriere JT, Smith BC.

Appl Spectrosc. 2014;68(7):758-76. doi: 10.1366/13-07329.

PMID:
25014842
17.

Influence of temperature on solvent-mediated anhydrate-to-hydrate transformation kinetics.

Qu H, Munk T, Cornett C, Wu JX, Bøtker JP, Christensen LP, Rantanen J, Tian F.

Pharm Res. 2011 Feb;28(2):364-73. doi: 10.1007/s11095-010-0281-9. Epub 2010 Oct 1.

PMID:
20886266
18.

Understanding the solid-state forms of fenofibrate--a spectroscopic and computational study.

Heinz A, Gordon KC, McGoverin CM, Rades T, Strachan CJ.

Eur J Pharm Biopharm. 2009 Jan;71(1):100-8. doi: 10.1016/j.ejpb.2008.05.030. Epub 2008 Jun 12.

PMID:
18590814
19.

Investigation of intrinsic dissolution behavior of different carbamazepine samples.

Sehić S, Betz G, Hadzidedić S, El-Arini SK, Leuenberger H.

Int J Pharm. 2010 Feb 15;386(1-2):77-90. doi: 10.1016/j.ijpharm.2009.10.051. Epub 2009 Nov 10.

PMID:
19900519
20.

In situ monitoring of carbamazepine-nicotinamide cocrystal intrinsic dissolution behaviour.

Qiao N, Wang K, Schlindwein W, Davies A, Li M.

Eur J Pharm Biopharm. 2013 Apr;83(3):415-26. doi: 10.1016/j.ejpb.2012.10.005. Epub 2012 Nov 16.

PMID:
23159709
Items per page

Supplemental Content

Write to the Help Desk